Form 4 for BV BrightView Holdings, Inc.
Accepted 2025-12-03 00:00:00 ET · period of report 2025-12-01 · accession 0001193125-25-306897 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-03 | 2025-12-02 | BV | Gottsegen Jonathan Mark | EVP, CLO, Corp. Sec | M - OptEx | — | +5,381 | 148.3K | +4% | — |
| D | 2025-12-03 | 2025-12-02 | BV | Gottsegen Jonathan Mark | EVP, CLO, Corp. Sec | F - Tax | $12.78 | -2,748 | 145.6K | -2% | -$35.1K |
| D | 2025-12-03 | 2025-12-01 | BV | Gottsegen Jonathan Mark | EVP, CLO, Corp. Sec | S - Sale+OE | $12.62 | -35.0K | 143.0K | -20% | -$441.7K |
| D | 2025-12-03 | 2025-12-02 | BV | Gottsegen Jonathan Mark | EVP, CLO, Corp. Sec | M - OptEx | $0.00 | -5,381 | 16.1K | -25% | $0 |
| D | 2025-12-03 | 2025-12-01 | BV | Gottsegen Jonathan Mark | EVP, CLO, Corp. Sec | A - Grant | $0.00 | +17.5K | 17.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-02 | M | A | 5,381 | — | 148,339 | D | — | — | (F2) Reflects restricted stock units that upon vesting converted into shares of Issuer common stock on a one-for-one basis. (F3) Includes shares of common stock acquired under the Issuer's employee stock purchase plan and unvested shares of restricted stock. Does not include unvested performance shares which will be reported when earned upon achievement of certain performance criteria. |
| 2 | Common | Common Stock | 2025-12-02 | F | D | 2,748 | $12.78 | 145,591 | D | — | — | (F3) Includes shares of common stock acquired under the Issuer's employee stock purchase plan and unvested shares of restricted stock. Does not include unvested performance shares which will be reported when earned upon achievement of certain performance criteria. |
| 3 | Common | Common Stock | 2025-12-01 | S | D | 35,000 | $12.62 | 142,958 | D | — | — | (F1) The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.52 to $12.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F3) Includes shares of common stock acquired under the Issuer's employee stock purchase plan and unvested shares of restricted stock. Does not include unvested performance shares which will be reported when earned upon achievement of certain performance criteria. |
| 4 | Derivative | Restricted Stock Units | 2025-12-02 | M | D | 5,381 | $0.00 | 16,143 | D | — · — to — | 5,381 Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units will be settled in either common stock or cash (or a combination thereof). (F7) Represents a grant of time-based restricted stock units that vest in four equal annual installments beginning on December 2, 2025. |
| 5 | Derivative | Restricted Stock Units | 2025-12-01 | A | A | 17,539 | $0.00 | 17,539 | D | — · — to — | 17,539 Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units will be settled in either common stock or cash (or a combination thereof). (F6) Represents a grant of time-based restricted stock units that vest in four equal annual installments beginning on December 1, 2026. |